Compound 2 induced remarkable apoptosis in human pancreatic tumor cells, characterized by the morphologies abnormity, the decrease in cell number and the ratio of Bcl-2 to Bax, in the 2-treated group compared with the control group. The gene discussed is BAX; the disease is pancreatic neoplasm.